陳錫賢(Chen, Hsi-Hsien) 教授

Email
d102093015@tmu.edu.tw
現   職
內科學科 教授

學經歷

學 歷

畢業學校與學位[修業時間]
台北醫學大學臨床醫學研究所 博士
2004/09~2010/06
台北醫學院醫學系 學士
1987/09~1994/06

本校學術經歷

任職單位與職稱[起迄時間]
內科學科教授
2022/08/01~
內科學科副教授
2017/02/01~2022/07/31
內科學科助理教授
2012/10/01~2017/01/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
台北醫學大學附設醫院專任主治醫師

專長與研究領域

學門領域
分子生物學
腎臟學
學術專長

論文著作

清冊下載


1. 2022 Hsueh Yu Mei,Chen Wei Jen,Lin Ying Chin,Huang Ya Li,Shiue Horng Sheng,Lin Yuh Feng,Hsieh Ru Lan,Chen Hsi Hsien,. Combined effects of nucleotide-binding domain-like receptor protein 3 polymorphisms and environmental metals exposure on chronic kidney disease . Scientific Reports .2022 ;(12)

2. 2022 Wu Yueh Lin,Lin Heng,Li Hsiao Fen,Don Ming Jaw,King Pei Chih,Chen Hsi Hsien. Salvia miltiorrhiza Extract and Individual Synthesized Component Derivatives Induce Activating-Transcription-Factor-3-Mediated Anti-Obesity Effects and Attenuate Obesity-Induced Metabolic Disorder by Suppressing C/EBPα in High-Fat-Induced Obese Mice . Cells .2022 ;(11)

3. 2021 Hsueh Yu Mei,Huang Ya Li,Lin Yuh Feng,Shiue Horng Sheng,Lin Ying Chin,Chen Hsi Hsien. Plasma vitamin B12 and folate alter the association of blood lead and cadmium and total urinary arsenic levels with chronic kidney disease in a Taiwanese population . Nutrients .2021 ;(13)

4. 2020 Wing Kiu Yeung,Hsiao-Fen Li,Cheng-Lin Chung,Kuang-Li Lee,Pei-Kuen Wei,Heng Lin, Hsi-Hsien Chene, Ji-Yen Cheng. Promising urinary miRNA biomarkers t-SPR profiling for urothelial cell carcinoma . Sensors and Actuators B: Chemical .2020 ;(322)

5. 2020 Yueh-Lin Wu,Hsiao-Fen Li,Hsi-Hsien Chen,Heng Lin. MicroRNAs as Biomarkers and Therapeutic Targets in Inflammation- and Ischemia-Reperfusion-Related Acute Renal Injury . International Journal o f Molecular Sciences .2020 ;(21)

6. 2020 Hsiao-Fen Li, Yueh-Lin Wu,Tzu-Ling Tseng,Shih-Wei Chao,Heng Lin,Hsi-Hsien Chen. Inhibition of miR-155 potentially protects against lipopolysaccharide-induced acute lung injury through the IRF2BP2-NFAT1 pathway . American Journal of Physiology-Cell Physiology .2020 ;(319):C1070-C1081

7. 2019 Chao-Hsiun Tang,Hsi-Hsien Chen,Ming-Ju Wu,Bang-Gee Hsu,Jer-Chia Tsai,Chi-Cheng Kuo, Shih-Pi Lin, Tso-Hsiao Chen, Yuh-Mou Sue. Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan . BMJ Open .2019 ;(9):1-8

8. 2019 Wu CY ,Wong CS,Chung CJ,Wu MY,Huang YL,Ao PL, Lin YF, Lin YC, Shiue HS, Su CT, Chen HH*, . The association between plasma selenium and chronic kidney disease related to . Journal of Hazardous Materials .2019 ;(375):224-232

9. 2019 Cheng Ching Feng,Ku Hui Chen,Cheng Jing Jy,Chao Shi Wei,Li Hsiao Fen,Lai Pei Fang,Chang Che Chang,Don Ming Jaw, Chen Hsi Hsien, Lin Heng. Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3 . Communications Biology .2019 ;(2):1-18

10. 2018 Tuyen Van Duong ,Te-Chih Wong , Hsi-Hsien Chen ,Tzen-Wen Chen,Tso-Hsiao Chen,Yung-Ho Hsu, Sheng-Jeng Peng, Ko-Lin Kuo, Chi-Sin Wang, I-Hsin Tseng, Yi-Wei Feng, Tai-Yue Chang, Chien-Tien Su, Shwu-Huey Yang. The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical crosssectional stusy . PLoS ONE .2018 ;(13):e0193742-e0193742

11. 2017 Chih-Wei Chen,Jan-Show Chu,Li-Chun Hsieh,Chih-Chin Kao,Yen-Chung Lin,Hsi-Hsien Chen. Intestinal goblet cell carcinoid presenting with recurrent sterile peritonitis in a patient on peritoneal dialysis: a case report . BMC Nephrology .2017 ;(18)

12. 2016 Hsi-Hsien Chen,Yi-Fan Lan,Hsiao-Fen Li,Ching-Feng Cheng,Pei-Fang Lai,Wei-Hua Li, Heng Lin. Urinary miR-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion–induced injury . scientific reports .2016 ;(6)

13. 2016 Hsiao-Chien Chen,Chung-Yi Cheng,Hsiu-Chen Lin,Hsi-Hsien Chen,Cheng-Hsien Chen,Chih-Ping Yang, Kai-Huei Yang, Chun-Mao Lin, Tsung-Yao Lin, Chwen-Ming Shih, Yu-Chuan Liu. Multifunctions of Excited Gold Nanoparticles Decorated Artificial Kidney with Efficient Hemodialysis and Therapeutic Potential . ACS Applied Materials & Interfaces .2016 ;(8):19691-19700

14. 2015 Mansoureh Z. Mousavi,Huai-Yi Chen,Kuang-Li Lee,Heng Lin,Hsi-Hsien Chen,Yuh-Feng Lin, Chung-Shun Wong, Hsiao Fen Li, Pei-Kuen Weia, Ji-Yen Cheng. Urinary micro-RNA biomarker detection usingcapped gold nanoslit SPR in a microfluidic chip . Analyst .2015 ;(140):4097-4104

15. 2015 Chih-Chin Kao,Jui-Yuan Hung,Shu-Ching Yeh,Chiao-Ying Hsu,Yen-Chung Lin,Tzen-Wen Chen, Hsi-Hsien Chen. Tacrolimus-induced acute demyelinating sensorimotor polyneuropathy with axonal damage after kidney transplantation . Acta Nephrologica .2015 ;(29):176-180

16. 2015 Te-Chih Wong,Yu-Tong Chen,Pei-Yu Wu,Tzen-Wen Chen,Hsi-Hsien Chen,Tso-Hsiao Chen, Shwu-Huey Yang. Ratio of Dietary n-6/n-3 Polyunsaturated Fatty Acids Independently Related to Muscle Mass Decline in Hemodialysis Patients . plos one .2015 ;(10):e01404

17. 2014 Lin H,Li HF,Chen HH,Lai PF,Juan SH,Chen JJ Cheng CF. Activating transcription factor 3 protects against pressure-overload heart failure via the autophagy molecule Beclin-1 pathway . Molecular Pharmacology .2014 ;(85):682-691

18. 2014 Chiu YF,Chen YC,Wu PY,Shih CK,Chen HH,Chen TH Yang SH. Association between the hemodialysis eating index and risk factors of cardiovascular disease in hemodialysis patients . Journal of Renal Nutrition .2014 ;(24):163-171

19. 2014 Chen HH,Lai PF,Lan YF,Cheng CF,Zhong WB,Lin YF Chen TW Lin H. Exosomal ATF3 RNA Attenuates Pro-Inflammatory Gene MCP-1 Transcription in Renal Ischemia-Reperfusion . Journal of Cellular Physiology .2014 ;(229):1202-1211

20. 2014 Chen HC,Lin HC,Chen HH,Mai FD,Liu YC,Lin CM, Chang CC, Tsai HY, Yang CP. Innovative strategy with potential to increase hemodialysis efficiency and safety . .2014 ;(4):4425

21. 2013 Lin H,Li HF,Lian WS,Chen HH,Lan YF,Lai PF, Cheng CF. Thromboxane A2 Mediates Iron-Overload Cardiomyopathy in Mice Through Calcineurin-Nuclear Factor of Activated T Cells Signaling Pathway . Circulation Journal .2013 ;(77):2586-2595

22. 2013 Lia PF,Cheng CF,Lin H,Tseng TL,Chen HH,Chen SH. ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression . Evidence-Based Complementary and Alternative Medicine .2013

23. 2013 Lin H,Lian WS,Chen HH,Lai PF,Cheng CF. Adiponectin ameliorates iron-overload cardiomyopathy through the PPARα-PGC-1-dependent signaling pathway . Mlecuar Pharmacology .2013 ;(84):275-285

24. 2012 Yi-Fan Lan,Hsi-Hsien Chen,Pei-Fang Lai,Ching-Feng Cheng,Yen-Ta Huang,Yi-Chao Lee, Tzen-Wen Chen, Heng Lin. MicroRNA-494 Reduces ATF3 Expression and Promotes AKI . JASN .2012 ;(23):2012-2023

25. 2012 Ting-Yun Lin,Chun-Cheng Chang,Chun-Chao Chan,Jui-Yu Yuan,Hsi-Hsien Chen. Cyclophosphamide-Rescued Plasmapheresis-Unresponsive Secondary Thrombotic Thrombocytopenic Purpura Caused by Sjögren's Syndrome . Archives of Medical Science .2012 ;(8):934-938

26. 2012 Hsi-Hsien Chen,Yen-Chung Lin,Tzen-Wen Chen,Heng Lin. The roles of adiponectin in acute kidney injury. . Journal of Experimental and Clinical Medicine .2012 ;(4):145-148

27. 2012 Chung-Te Liu,Tso-Hsiao Chen,Hsi-Hsien Chen,Yen-Chung Lin,Tzen-Wen Chen. Effect of Sitagliptin on Blood Pressure and Estimated Glomerular Filtration Rate in Diabetic Patients Using an Angiotensin II Receptor Blocker . Journal of Experimental and Clinical Medicine .2012 ;(4):334-337

28. 2010 Ching-Feng Cheng,Hsi-Hsien Chen,Heng Lin. Role of PPAR α and Its Agonist in Renal Diseases . PPAR Research .2010 ;(345098):1-6

29. 2010 Hsi-Hsien Chen,Tzen-Wen Chen,Heng Lin. Pravastatin Attenuates Carboplatin-Induced Nephrotoxicity in Rodents via Peroxisome Proliferator-Activated Receptor α-Regulated Heme Oxygenase-1 . Mol Pharmacol .2010 ;(78):36-45

研究計畫

計畫名稱
113 探討腎週圍脂肪組織中白色脂肪分化成棕/褐脂肪後所產生的脂肪因子以改善慢性腎損傷之基礎暨臨床轉譯醫學研究(2/3)
補助單位
國家科學及技術委員會

計畫名稱
112 探討腎週圍脂肪組織中白色脂肪分化成棕/褐脂肪後所產生的脂肪因子以改善慢性腎損傷之基礎暨臨床轉譯醫學研究(1/3)
補助單位
國家科學及技術委員會

計畫名稱
110 探討由中草藥丹蔘衍生之單一化合物及微小核糖核酸494在肥胖引發糖尿病導致腎病變之轉譯醫學研究
補助單位
科技部

計畫名稱
109 利用超高速藥物篩選平台鑑定活化轉錄因子3之小分子活化劑及其對慢性腎臟病之治療效果
補助單位
科技部

計畫名稱
108 探討以特定微型核糖核酸-328-5p/6885-5p作為診斷及治療顯影劑引發之腎病變的標的(3/3)
補助單位
科技部

計畫名稱
107 探討以特定微型核糖核酸-328-5p/6885-5p作為診斷及治療顯影劑引發之腎病變的標的(2/3)
補助單位
科技部

計畫名稱
106 探討以特定微型核糖核酸-328-5p/6885-5p作為診斷及治療顯影劑引發之腎病變的標的(1/3)
補助單位
科技部

計畫名稱
105 C/EBP β 調控microRNA-16之分子機轉及臨床應用(2/2)
補助單位
科技部

計畫名稱
105 C/EBP β 調控microRNA-16之分子機轉及臨床應用(2/2)
補助單位

計畫名稱
104 C/EBP β 調控microRNA-16之分子機轉及臨床應用(1/2)
補助單位
科技部

計畫名稱
104 C/EBP β 調控microRNA-16之分子機轉及臨床應用(1/2)
補助單位
科技部

計畫名稱
103 探討微小核糖核酸-16在急性腎損傷之作用機轉及應用
補助單位
科技部